Declaring the Identity and Patent Status of the Pharmaceutical Product
The pharmaceutical company must complete and submit to the Commissioner of Patents one of
the forms listed below. The company should choose the form that corresponds to the schedule on which the
importing country appears, as well as the patent status of the pharmaceutical product in that country. The
application must be accompanied by a certified
copy of the importing country's notification and any other declarations made by the country.
If the importing country appears on Schedule
2 and is a  World Trade Organization
(WTO) member, and the pharmaceutical product is not patented in that country, choose
- "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(i)(A)
of the Patent Act" (
 45 kB;
 42 kB)
If the importing country appears on Schedule
2 and is a WTO member, and the pharmaceutical product is
patented in that country, choose
- "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(i)(B)
of the Patent Act" (41 kB;
39 kB)
If the importing country appears on Schedule
2 and is not a WTO member, and the pharmaceutical product
is not patented in that country, choose
- "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(ii)(A)
of the Patent Act" (45 kB;
42 kB)
If the importing country appears on Schedule
2 and is not a WTO member, and the pharmaceutical product
is patented in that country, choose
- "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(ii)(B)
of the Patent Act" (41 kB; 40 kB)
If the importing country appears on Schedule
3 or Schedule 4,
and the pharmaceutical product is not patented in that country,
choose
- "Solemn or Statutory Declaration Under Clause 21.04(3)(d)(iii)(A),
(iv)(A) or (v)(A) of the Patent Act" (41 kB;
41 kB)
|
